Increased blood loss associated with administration of certain plasma expanders: dextran 75, dextran 40, and hydroxyethyl starch.
D000768:Anesthesia, General; D000818:Animals; D001158:Arteries / Q000293:injuries; D001777:Blood Coagulation / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D003911:Dextrans / Q000009:adverse effects*; D004285:Dogs; D005340:Fibrinogen / Q000378:metabolism; D006470:Hemorrhage / Q000139:chemically induced / Q000628:therapy; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011517:Prothrombin Time; D013213:Starch / Q000009:adverse effects*
D003911:Dextrans; D010952:Plasma Substitutes; D005340:Fibrinogen; D013213:Starch